Sign In
Buy BPTH
$0.0300
+0.0066 (+28.21%)
At Close: Jun 03, 2026
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:14am, Monday, 09'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ObsEva SA (OBSV) and Bio-Path Holdings (BPTH) with bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
11:14am, Monday, 09'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ObsEva SA
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) Arcus Biosciences Inc (NYSE: RCUS ) Arcturus Th
24 Stocks Moving in Friday's Pre-Market Session
12:20pm, Friday, 06'th Mar 2020
Gainers
NanoViricides, Inc. (NYSE: NNVC) shares rose 41.7% to $11.45 in pre-market trading after Small Caps Daily issued a press release discussing the company's coronavirus...
Bio-Path Holdings Reports Full Year 2019 Financial Results
12:00pm, Friday, 06'th Mar 2020
Bio-Path Holdings, Inc., (BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, tod
Bio-Path Holdings, Inc. to Host Earnings Call
11:30am, Friday, 06'th Mar 2020
NEW YORK, NY / ACCESSWIRE / March 6, 2020 / Bio-Path Holdings, Inc. (BPTH) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 6, 2020 at 8:30 AM E
Earnings Scheduled For March 6, 2020
04:35am, Friday, 06'th Mar 2020
Companies Reporting Before The Bell DXP Enterprises, Inc. (NASDAQ: DXPE) is estimated to report quarterly earnings at $0.60 per share on revenue of $319.97 …
85 Biggest Movers From Yesterday
10:04am, Wednesday, 04'th Mar 2020
Gainers
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) shares climbed 69.7% to close at $7.45. Inovio Pharmaceuticals announced an accelerated timeline Tuesday for the development of...
Bio-Path Holdings to Announce Fourth Quarter and Full Year 2019 Financial Results on March 6, 2020
01:00pm, Friday, 28'th Feb 2020
HOUSTON, Feb. 28, 2020 -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to.
Bio-Path Holdings to Announce Fourth Quarter and Full Year —…–9 Financial Results on ...
12:00am, Friday, 28'th Feb 2020Does Bio-Path Holdings, Inc.'s (NASDAQ:BPTH) CEO Salary Compare Well With Others?
03:34pm, Friday, 21'st Feb 2020
Peter Nielsen became the CEO of Bio-Path Holdings, Inc. (NASDAQ:BPTH) in 2008. This analysis aims first to contrast...
35 Healthcare Stocks Moving In Tuesday's Pre-Market Session
01:25pm, Tuesday, 18'th Feb 2020
Gainers
Stealth BioTherapeutics, Inc. (NASDAQ: MITO) stock increased by 38.4% to $3.10 during Tuesday's pre-market session. According to the most recent rating by H...
Zacks.com featured highlights include: Denny's, Heico, Oasis Midstream Partners, NV5 Global and Bio-Path
02:07pm, Thursday, 23'rd Jan 2020
Zacks.com featured highlights include: Denny's, Heico, Oasis Midstream Partners, NV5 Global and Bio-Path
